Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003203)

(Analysis AN005253)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12
Orn	ME835320	0.26	2.84	3.01	0.49	0.43	NA	0.17	0.19	NA	0.03	0.25	NA
alpha-AAA	ME835305	NA	NA	NA	1.21	0.48	2.50	NA	0.11	0.22	0.38	NA	0.70
Anserine	ME835306	0.73	0.71	1.35	0.73	0.61	0.68	1.31	0.88	0.64	3.83	0.73	0.86
5-AVA	ME835301	1.11	0.64	0.72	0.69	1.25	0.72	2.35	1.02	0.60	1.01	0.74	0.72
Betaine	ME835308	0.56	1.82	1.04	1.01	0.92	1.54	1.08	0.60	0.65	0.84	0.96	0.98
Gln	ME835284	0.78	0.35	1.72	0.67	1.65	0.96	0.78	1.52	0.82	1.36	0.79	1.11
Taurine	ME835327	1.01	0.27	1.47	0.72	1.50	1.05	0.65	1.30	0.84	1.84	0.87	1.01
3-Met-His	ME835300	0.86	1.10	1.43	0.49	1.06	1.13	0.82	1.29	0.61	1.96	0.69	0.74
Ala	ME835279	1.13	0.91	1.79	0.45	1.45	0.94	0.87	0.94	0.48	2.20	0.65	0.70
Phe	ME835292	1.23	0.59	1.77	0.63	1.39	1.00	1.16	0.80	0.20	2.10	0.39	0.60
PAG	ME835321	0.66	1.06	1.27	0.81	1.06	0.97	0.87	0.64	0.64	1.12	1.38	1.89
Gly	ME835286	0.85	0.73	1.59	1.02	1.08	0.62	0.86	0.88	1.37	0.89	1.02	0.72
HCys	ME835316	0.89	0.93	0.95	1.04	0.87	0.81	1.02	0.80	1.68	0.93	0.90	0.77
TrpBetaine	ME835328	0.97	0.86	1.31	0.66	1.13	1.13	1.22	0.72	1.02	0.65	0.98	0.95
t4-OH-Pro	ME835326	0.89	0.76	1.08	0.75	1.03	1.37	0.86	1.14	0.84	1.44	1.08	1.10
TMAO	ME835278	0.88	0.84	0.79	0.87	1.19	0.77	1.13	1.16	1.10	1.10	1.05	1.15
Creatinine	ME835312	0.99	0.71	1.19	0.84	1.13	1.07	0.93	1.14	0.93	1.32	0.95	1.01
Sarcosine	ME835324	0.89	0.92	1.04	0.86	1.25	0.90	0.99	1.20	0.88	1.30	0.91	1.14
BABA	ME835307	1.16	1.05	1.22	0.80	1.16	0.92	0.95	1.18	0.85	1.02	0.87	0.96
Leu	ME835289	1.08	0.96	1.20	0.84	1.11	0.81	1.22	1.00	0.75	1.09	0.94	1.00
Met-SO	ME835318	1.03	0.88	1.20	0.89	1.08	0.92	1.06	1.03	0.88	1.09	0.92	1.10
His	ME835287	0.97	0.84	1.32	1.08	1.15	1.01	0.93	0.96	0.92	1.01	0.91	0.87
ProBetaine	ME835323	0.92	0.93	1.03	1.10	0.91	0.94	0.98	0.97	1.26	1.06	0.91	0.88
Kynurenine	ME835317	0.97	1.02	1.03	1.05	1.06	0.99	0.96	1.00	0.90	1.08	1.06	0.91
DOPA	ME835314	0.99	0.97	1.00	0.99	1.01	1.01	0.99	1.06	0.93	0.95	1.03	1.18
AABA	ME835302	0.96	0.94	1.01	0.97	1.06	1.05	0.97	1.01	0.94	1.12	1.01	1.05
Carnosine	ME835310	0.97	1.02	1.02	0.98	1.01	1.02	0.98	0.99	0.98	1.02	0.99	1.07
Met	ME835291	1.00	1.00	1.00	1.00	0.99	1.01	1.00	1.01	1.00	0.99	1.00	1.01
1-Met-His	ME835299	0.61	0.92	1.21	0.86	1.04	1.04	1.33	1.28	1.05	1.10	0.77	0.83
PheAlaBetaine	ME835322	0.68	1.38	1.06	0.88	1.06	1.06	1.06	1.06	1.06	1.32	0.86	0.66
Cystine	ME835313	0.80	0.90	0.89	1.21	1.19	1.07	1.15	1.09	0.92	1.09	0.97	0.67
HArg	ME835315	0.84	1.07	1.25	1.07	1.31	1.10	1.05	0.89	0.85	1.16	0.79	0.63
ADMA	ME835304	0.92	0.90	1.34	1.02	1.10	1.07	0.82	1.26	0.55	0.94	1.14	1.32
Trigonelline	ME835277	0.70	0.75	1.00	1.13	1.00	1.32	1.03	0.89	0.90	0.84	1.23	1.17
Cys	ME835283	0.95	1.02	1.88	0.88	0.74	0.89	0.95	1.70	0.56	1.07	0.84	0.89
SDMA	ME835325	1.04	0.78	1.28	0.78	1.42	0.78	1.38	1.07	0.62	1.28	0.76	1.07
Ile	ME835288	0.98	0.90	1.53	0.80	1.11	0.69	1.40	1.04	0.76	0.94	0.80	0.91
Tyr	ME835297	1.13	0.95	1.59	0.79	1.18	0.74	1.41	1.04	0.51	1.14	0.70	0.88
Asp	ME835282	1.01	0.78	1.51	0.75	1.24	0.91	1.31	0.98	0.64	1.20	0.82	0.87
Pro	ME835293	1.03	0.99	1.37	0.84	1.15	0.87	1.28	1.06	0.61	1.21	0.79	0.96
Asn	ME835281	0.92	0.84	1.44	0.67	1.08	1.04	1.08	1.35	0.58	1.35	0.87	1.25
Glu	ME835285	1.14	0.65	1.49	0.79	1.25	1.08	0.96	1.13	0.72	1.26	0.77	1.03
Val	ME835298	1.08	0.69	1.81	0.57	1.43	0.61	1.45	0.99	0.24	1.38	0.72	0.80
Thr	ME835295	1.12	0.93	1.95	0.74	1.18	0.65	1.36	1.06	0.46	1.12	0.65	0.86
Cit	ME835311	1.35	1.11	1.94	0.88	1.01	0.71	1.27	0.83	0.55	0.94	0.59	0.77
Ser	ME835294	1.12	1.04	2.06	0.80	1.09	0.70	1.39	0.92	0.51	0.96	0.60	0.70
Arg	ME835280	1.32	0.90	1.96	0.83	1.19	0.81	0.81	0.81	0.60	1.39	0.39	0.47
Trp	ME835296	1.04	0.52	2.15	1.07	1.18	0.74	1.09	0.86	0.44	1.44	0.65	1.03

Factors:

F1	Sample source:Tear \| Study Arm:1 \| Timepoint:Week 10 \| PZC (< 660 ug/L):N
F2	Sample source:Tear \| Study Arm:1 \| Timepoint:Week 10 \| PZC (< 660 ug/L):Y
F3	Sample source:Tear \| Study Arm:1 \| Timepoint:Week 18 \| PZC (< 660 ug/L):N
F4	Sample source:Tear \| Study Arm:1 \| Timepoint:Week 18 \| PZC (< 660 ug/L):Y
F5	Sample source:Tear \| Study Arm:1 \| Timepoint:Week 2 \| PZC (< 660 ug/L):N
F6	Sample source:Tear \| Study Arm:1 \| Timepoint:Week 2 \| PZC (< 660 ug/L):Y
F7	Sample source:Tear \| Study Arm:2 \| Timepoint:Week 10 \| PZC (< 660 ug/L):N
F8	Sample source:Tear \| Study Arm:2 \| Timepoint:Week 10 \| PZC (< 660 ug/L):Y
F9	Sample source:Tear \| Study Arm:2 \| Timepoint:Week 18 \| PZC (< 660 ug/L):N
F10	Sample source:Tear \| Study Arm:2 \| Timepoint:Week 18 \| PZC (< 660 ug/L):Y
F11	Sample source:Tear \| Study Arm:2 \| Timepoint:Week 2 \| PZC (< 660 ug/L):N
F12	Sample source:Tear \| Study Arm:2 \| Timepoint:Week 2 \| PZC (< 660 ug/L):Y

Data matrix